Amy Kang
0000-0002-0300-1282
George Institute for Global Health
5 papers found
Refreshing results…
The sodium‐glucose cotransporter‐2 inhibitor canagliflozin does not increase risk of non‐genital skin and soft tissue infections in people with type 2 diabetes mellitus: A pooled post hoc analysis from the CANVAS Program and CREDENCE randomized double‐blind trials
SGLT2 inhibitors may offer benefit beyond diabetes
Prevalence, incidence and risk factors of diabetes in Australian adults aged ≥45 years: A cohort study using linked routinely-collected data
EXamining ouTcomEs in chroNic Disease in the 45 and Up Study (the EXTEND45 Study): Protocol for an Australian Linked Cohort Study
Dr. Kang, et al reply
Missing publications? Search for publications with a matching author name.